Highlights

  • Austco Healthcare (ASX:AHC) completed the Acquisition of Medical Communications Systems.
  • The company continues expanding its healthcare communications technology platform.
  • Austco secured a A$4.2 million maintenance contract in Singapore.
  • FY26 guidance highlighted Revenue growth and improving Earnings expectations.

Austco Healthcare Limited (ASX:AHC) continues to expand its healthcare communications technology Business following acquisition activity and new contract wins across key markets. The company remains focused on growing its direct sales presence, Recurring Revenue base and international healthcare technology footprint.

At the time of writing on 25 August 2026, Austco Healthcare was trading at AUD 0.23, up 4.55%, as investors continued assessing recent corporate developments and the company’s FY26 growth outlook.

Business Update

Austco Healthcare (ASX:AHC) recently completed the acquisition of Medical Communications Systems (MCS), a long-standing certified reseller in South Australia.

The acquisition forms part of the company’s strategy of bringing established regional resellers into its direct operating structure, allowing greater control over customer relationships and distribution channels.

The transaction follows previous acquisitions including Teknocorp in 2023, Amentco in 2024 and G&S Technologies in 2025, as Austco continues expanding its healthcare communications offering.

Contract Growth

Prior to the MCS acquisition completion, Austco secured a A$4.2 million maintenance contract in Singapore in July 2026.

The contract adds to the company’s recurring service revenue base and supports its presence in the Asian healthcare market.

Austco continues to provide nurse-call and clinical communication solutions through its Tacera platform and newer mobile technology offerings, including Pulse Mobile, across hospitals and aged care providers.

FY26 Outlook

Austco’s FY26 trading update highlighted expectations for continued growth across revenue and earnings.

The company guided FY26 revenue to $90–95 million, compared with $81.4 million in FY25. EBITDA was guided at $14.0–14.6 million, compared with $13.0 million in the prior year.

Gross Margin was expected to improve to around 52.8% from 52.0%, while EBITDA margin was forecast at approximately 15.5%.

Net profit after tax was guided to $9.0–9.4 million, compared with $5.9 million in FY25. The company noted that the forecast includes a one-off $1.0 million benefit related to a reduction in contingent consideration liabilities from earlier acquisitions.

Growth Strategy

Austco’s growth strategy combines organic expansion with acquisitions and recurring service revenue opportunities.

The company has highlighted several healthcare technology deployments, including a major US rollout of the Pulse Mobile platform across approximately 180 hospitals during the 2026 calendar year.

Other contract wins have included a NZ$1.1 million New Zealand residential portfolio deal, a $1.1 million Warrnambool Hospital expansion and a $0.9 million North York General Hospital project in Canada.

These initiatives support Austco’s broader objective of expanding its presence across international healthcare markets.

Market Focus

Investor interest in Austco Healthcare has centred on its position within the healthcare communications technology sector and its acquisition-led expansion strategy.

The company’s combination of recurring maintenance revenue, healthcare technology solutions and direct customer relationships provides a framework for continued growth.

The completed MCS acquisition also strengthens Austco’s Australian market presence by transitioning an established reseller relationship into the company’s operating structure.

Growth Drivers

Potential growth drivers for Austco include further healthcare contract wins, expansion of recurring service revenue and continued integration of acquired businesses.

Growth in the US hospital market through the Pulse Mobile rollout represents an important opportunity, while additional acquisitions could support further expansion.

Successful execution of the company’s strategy will remain important for improving scale and operational efficiency.

Key Risks

Austco’s FY26 update highlighted Supply chain pressures and more challenging trading conditions during the second half of the year.

The company also faces execution risks associated with integrating acquisitions and maintaining growth while managing costs.

The difference between trailing earnings trends and FY26 guidance will require monitoring as the company reports full-year results. As a smaller company, trading Liquidity may also contribute to share price volatility.

What Comes Next?

The next major milestone for Austco Healthcare will be the release of its FY26 annual results, which will provide further detail on actual revenue, earnings performance and MCS integration.

Investors will also monitor progress on the Pulse Mobile rollout, recurring revenue growth and potential future acquisitions.

Further updates on margins and operating conditions will provide insight into the company’s ability to deliver its growth objectives.

Final Take

Austco Healthcare (ASX:AHC) continues to expand its healthcare communications technology business through acquisitions, contract wins and international growth initiatives. The completed MCS acquisition and Singapore maintenance contract add to the company’s development pathway, while FY26 results will provide further clarity on earnings performance, integration progress and future growth opportunities.